DR. OSAMA SULTAN 15 SEPTEMBER 2014 Otto Heinrich Warburg 1883 - 1970 German biochemists Nobel price 1931 for the discovery of G6PD enzyme.

Slides:



Advertisements
Similar presentations
Glucose 6-phosphate dehydrogenase deficiency
Advertisements

By: Alejandra Arellano
Case Study MICR Hematology Spring, 2011
Physiology Department Esraa Raafat Ahmed Ghanem 92 - Esraa Reda Hashem Tawfik 93 -Esraa samy Farid Abd Elghaffar 94 -Esraa Saad Abbas Hamed 95 -Esraa.
Enzymopathies = ENZYME DEFECTS
Neonatal Jaundice By Dr. Nahed Al-Nagger
Bilirubin Metabolism & Jaundice
RHY/CH00561 Biology of Disease CH0576 Hyperbilirubinaemia & Jaundice II.
Pentose Phosphate Pathway Generation of NADPH and Pentoses.
Anemia Dr Gihan Gawish.
DR. SAIDUNNISA, MD Professor of Biochemistry Hexose monophosphate shunt.
Clinical aspects of Maternal and Child Nursing NUR 363 Lecture 8.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
Dr. Saidunnisa, MD Professor of Biochemistry
MLAB 1415-Hematology Keri Brophy-Martinez
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Alterations in Liver Function.
Neonatal Jaundice Hyperbilirubinemia Fred Hill, MA, RRT.
FATIMA DARAKHSHAN (2K10-BS-V&I-35)
Glucose-6-phosphate Dehydration Deficiency Nada Mohamed Ahmed, MD, MT (ASCP)i.
Genetic Diseases (1)Sickle-cell anaemia 鐮刀形紅血球貧血症.
Hemolytic Anemias Defined as those anemias result from an increased in the rate of red cell destruction. The red cell destruction is usually removed extravascular.
HEREDITARY HAEMOLYTIC ANAEMIAS BY DR. FATMA ALQAHTANI CONSULTANT HAEMATOLOGIST ENZYMOPATHIES GLUCOSE - 6 – PHOSPHATE DEHYDROGENASE DEFICIENCY.
Malaria Jessy Cockrell.
PENTOSE PHOSPHATE SHUNT or HEXOSE MONOPHOSPHATE PATHWAY This pathway consists of two parts: 1) Glucose-6-P undergoes two oxidations by NADP +, the second.
Jaundice Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Genes vs. Environment (Nature vs. Nurture) Is everything determined by genetics? Your characteristics (phenotype) are often a combination of your genotype.
Gilbert’s syndrome Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Gilbert’s syndrome? Gilbert’s Syndrome is.
Quality Education for a Healthier Scotland Multidisciplinary Neonatal Jaundice Promoting multiprofessional education and development in Scottish maternity.
Sickle Cell Anemia. P. falciparum – Blood stages Uninfected RBC 2 hr. 4 hr. 12 hr.
Case Study #1 You are an Army officer during the Korean War, and are in charge of a group of soldiers preparing to deploy from Fort Dix, New Jersey. In.
Glucose -6-phosphate dehydrogenase deficiency
Case Study 1: G6PD David Grkovicious Andrew Wattals Tim Cryal.
Glucose-6-Phosphate Dehydrogenase
PharmacogeneticsPharmacogenetics Dr, P Derakhshandeh, PhD Dr, P Derakhshandeh, PhD.
Malaria By Alexandra Graziano 10 White What is this disease? Malaria is an infection of the blood caused by a parasite called Plasmodium, which.
GLUCOSE-6-PHOSPATE DEHYDROGENASE DEFICIENCY GENETICS PRESENTATION BY GROUP A2(MD2) WINDSOR UNIVERSITY SCHOOL OF MEDICINE. IVEREN,FOLA,FLOURISH, ALLISON,
Thalassemia & Treatment. What is thalassemia? Genetic blood disorder resulting in a mutation or deletion of the genes that control globin production.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
Glucose-6-Phosphate Dehydrogenase
Glucose 6-phosphate dehydrogenase deficiency HMIM224.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
HEPATITIS A EISENMAN ARIE, M.D Department of Internal Medicine B Rambam Medical Center Haifa, Israel
MLAB 1415-Hematology Keri Brophy-Martinez Hemolytic Anemias: Enzyme Deficiencies.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
Inherited and acquired haemolytic anaemias
Glucose-6-Phosphate Dehydrogenase
The complications can be broadly classified into two categories: Immune Complications Non-immune Complications.
Glucose-6-phosphate Dehydration Deficiency
Red cell membrane defects. Hereditary spherocytosis (HS) The most common of the inherited RBC membrane defects, affecting 1 in 5000 individuals. The disorder.
Overviw Red cell enzyme Red cell enzyme Glucose-6-phosphate dehydrogenase deficiency Glucose-6-phosphate dehydrogenase deficiency Causes: Causes: Symptoms.
Neonatal Jaundice 新生兒黃疸. History 病人是自然產出生一天大的男嬰;母親 是 24 歲 G2P1A1 客家人,產前實驗室檢 查正常,懷孕過程順利, group B streptococcus 檢查是陰性,母親血型是 O positive ,破水時間是 1 小時。男嬰出 生體重是.
Sickle Cell Trait: Know Your Status Jacqueline Rodriguez-Louis, MPH, M.Ed.
Sickle-Cell Anemia Katie Baska. What is Sickle-cell Anemia? An inherited disease that results in the production of abnormal hemoglobin in red blood cells.
MLAB Hematology Keri Brophy-Martinez Fall 2007 Unit 13: Hemolytic Anemias: Intracorpuscular Defects/ Hemoglobinopathies.
Done by : Bara Shayib Supervised by : Dr. Abdullateef Alkhateeb.
Background notes Audience: diabetes professional (entry level), patients with diabetes First slide: ADD your name/institution ‘Sponge bob’ slide: hemoglobin.
MANGEMENT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
Glucose-6-Phosphate Dehydrogenase Deficiency
Glucose-6-PhosphateDehydrogenase Deficiency Glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most frequent disease involving enzymes of the.
Red cell membrane defects
Pentose Phosphate Pathway
ARULANANDAM TERENCE.T 403(A)
Practical Hematology Lab Glucose 6 Phosphate Dehydrogenase
PENTOSE PHOSPHATE SHUNT or HEXOSE MONOPHOSPHATE PATHWAY
Glucose-6-Phosphate Dehydrogenase
Practical Hematology Lab Glucose 6 Phosphate Dehydrogenase
Practical Hematology Lab Glucose 6 Phosphate Dehydrogenase
Approach to Haemolysis
Sickle cell disease By Mayu & Jovany.
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
Presentation transcript:

DR. OSAMA SULTAN 15 SEPTEMBER 2014

Otto Heinrich Warburg German biochemists Nobel price 1931 for the discovery of G6PD enzyme.

Ernest Beutler (1928 – 2008)

Epidemiology G6PD deficiency is the most prevalent red cell enzymes deficiency in the world. 350 – 400 Million people are affected worldwide ( prevalence about 5 – 10%) Coincides with the geographic distribution of endemic malaria. The highest prevalence is in Sub-Saharan Africa, followed by middle East, Mediterranean Europe, and Southeast Asia X-linked recessive inheritance pattern

Polymorphic variants od G6PD confer a survival benefit in malaria-endemic region. Mild G6PD variant have protection against severe Plasmodium falciparum malaria ( 58% risk reduction in male hemizygotes, and 46% reduction in female heterozygotes). Explanation :?? Increased phagocytosis of G6PD-deficient erythrocytes containing the early ring-stage parasites. the level of reduced glutathione was lower in the G6PD- deficient cells compared with normal red cells, leading to membrane damage of deficient cells containing parasites that may be preferentially targeted for destruction. G6PD deficiency prevalence among HIV patients about 6.8%.

G6PD GENE AND ENZYME

G6PD variants genotypes/Isoenzymes G6PD B+ : wild type, whites > blacks G6PD A+ : blacks > whites G6PD A- : blacks with mild deficiency G6PD Med : whites Mediterranean, Kurdish, severe def. G6PD Canton : Thailand, Vietnam, Taiwan WHO variants

Most people with G6PD deficiency have no symptoms and are not anemic. In fact, the majority of affected individuals live out their lives unaware of their status. The disease is generally manifest when the red cells undergoes oxidative stress triggered by: Certain drugs Infections Ingestion of fava beans Medical conditions such as DKA, liver disease, renal disease

G6PD deficiency usually presents as: drug-induced acute hemolytic episode Infection-induced acute hemolytic episode Favism Neonatal jaundice Congenital non-spherocytic hemolytic anemia (CNSHA) G6PD deficiency does not seem to affect life expectancy, quality of life, or the activity of affected individuals.

Drug-induced Acute hemolytic episode Primaquine was the first drug encountered in causing acute hemolysis. It is difficult to establish that drugs is directly related to triggering this type of hemolytic episode because: Some drugs are safe for individuals but not for all Coexistence of another trigger e.g. infection, diabetes, hemoglobinopathies, etc. Some patients take more than one drugs Self-limiting process so it may pass unnoticed !!

The symptoms start after ingesting the offending drug by 2 to 4 days. Fatigue, jaundice, pallor, abdominal or back pain, and dark urine. Self-limiting, but may be prolonged in severe variants, with an average of 7 – 1o days after onset of hemolysis. There are 7 known drugs that cause such hemolysis according to EBM, but the list is evolving.

Dapsone Methylene blue Toluidine blue Phenazopyridine Primaaquine Rasburicase Nitrofurantion

Infection-induced Acute Hemolytic Episode The most common trigger of hemolysis Occurs after 1-2 days from onset of febrile illness. commonly associated with pneumonia or typhoid fever. Organisms can be: Bacterial: ß-hemolytic sterptococci, E.coli, Salmonella Richettial infections Viral: hepatitis A,B; CMV, EBV, influenza A The severity of haemolysis can be aff ected by many factors, including concomitant drug administration, liver function, and age.

Acute renal failure may be a serious complication after viral infection in adult secondary to Acute tubular necrosis due to renal ischemia Tubular obstruction by hemoglobin casts

Favism Second most common trigger of hemolysis % in patients Seen in severe G6PD variants Within hrs from eating or inhaling fava beans More in children and breast-fed babies More with fresh fava beans; but dried and freezed ones can do. Also peanuts can trigger favism !! Depends on amount, type, mode of cooking.

Divicine, isouramil, and convicine, which are thought to be the toxic constituents ( about 2% of total weight ) of fava beans, increase the activity of the hexose monophosphate shunt, promoting hemolysis in G6PD-deficient patients.

Broad beans Kidney red beans

Alfaalfa sprouts Astragalus Fenugreek

Carob (chocolate substitute) Liquorice Tamarind

Congenital Non-spherocytis Hemolytic Anemia(CNSHA) Seen in class I G6PD variant Very rare, sporadic Chronic hemolysis Independent mutations clustering in exons 10 and 11. Infants present with severe neonatal jaundice, or discovered later when present with mild anemia that that exacerbated by oxidant stress.

Neonatal Jaundice Seen in neonate with severe G6PD variants Hyperbilirubinemia is likely secondary to impairment of bilirubin conjugation and clearance by the liver leading to indirect hyperbilirubinemia. Infants with G6PD deficiency and a mutation of uridine diphosphoglucuronate glucuronosyltransferase-1 gene promoter (UDPGT-1) are particularly susceptible to hyperbilirubinemia secondary to decreased liver clearance of bilirubin. UDPGT-1 is the enzyme affected in Gilbert disease.

If not treated, may lead to kernicterus (over 30%)and mental retardation and even death.

Laboratory Manifestations Qualitative test Fluorescent spot test Simple Inexpensive NADPH production is detected by virtue of its fluorscent under ultraviolet light G6P and NADP+ are added to a hemolysate of the patient’s red cells Fluorescence under ultraviolet light indicates enzyme activity, whereas absence of fluorescence indicates enzyme deficiency False negative results during acute hemolytic episode, repeat the test after 4 – 6 weeks.

Quantitative spectrophotometric analysis Molecular diagnostic testing

Management Straightfarward … Stop the offending drug Avoid fava beans, or any other oxidant stersses Adequate intake of fluids Treat infection with appropriate antibiotic Blood transfusion if severe anemia Phototherapy and exchange transfusion for neonatal jaundice Folic acid supplementation

G6PD deficiency is the most common red cell enzymopathies world wide. There are different variants and mutations that determine the severity of the disease which get periodically updated. Hemolysis is usually triggered by certain drugs and infections in addition to some medical conditions and fava bean ingestion. Chinese herbs can trigger hemolysis in some patients.

THANK YOU ALL